New generation of aromatase inhibitors: Prospects of a major advantage for the patients

Annals of Oncology

Volumn 7, Issue 5, 1996, Pages 433-437

  Cocconi, G ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; AROMATASE INHIBITOR; EXEMESTANE; FADROZOLE; FORMESTANE; HYDROCORTISONE; LETROZOLE; PYRIDOGLUTETHIMIDE; TAMOXIFEN; VOROZOLE;

CANCER CHEMOTHERAPY; EDITORIAL; FEMALE; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL;

EID: 0030016492     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010629     Document Type: Editorial

References (10)

1. Early Breast Cancer Trialist’s Collaboration Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or Immune therapy Lancet 339 1992 1 15 71–85
2. Brodie A.M.H. Santen R.J. Aromatase and its inhibitors in breast cancer treatment Breast Cancer Res Treat 30 1994 1 111 (special issue)
3. Cocconi G. First generation aromatase inhibitors – aminoglut- ethimide and testololactone Breast Cancer Res Treat 30 1994 57 80
4. Cocconi G. Bisagni G. Ceci G. Low-dose aminoglutethimide with or without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research J Clin Oncol 10 1991 984 989
5. Goss P.E. Gwyn M.E.H. Current perspectives on aromatase inhibitors in breast cancer J Clin Oncol 12 1994 2460 2470
6. Miller W.R. Aromatase inhibitors – where are we now? Br J Cancer 73 1996 415 417
7. Steele R.E. Mellor L.B. Sawer W.K. In vivo and in vitro studies demonstrating potent and selective estrogen inhibition with nonsteroidal aromatase inhibitor CGHS 16949A Steroids 50 1987 147 161
8. Santen R.J. Demers L.M. Adlercreutz H. Inhibition of aromatase with CGS 16949A in postmenopausal women J Clin Endocrinol Metab 68 1989 99 106
9. Stein R.C. Dowsett M. Davenport J. Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A Cancer Res 50 1990 1381 1384
10. Murray R. Pitt P. Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer Breast Cancer Res Treat 35 1995 249 253